H.R. 880, American Research and Competitiveness Act of 2015; 
H.R. 1430, Permanent CFC Look-Through Act;
S. 2260, Expiring Provisions Improvement, Reform, and Efficiency (EXPIRE) Act of 2014;
Innovation Promotion Act of 2015 (Not yet introduced);
Administrations Tax Reform and 2015 Budget Proposals; 
Senate and House Committee Tax Reform Proposals; 
Proposals to reform domestic and international tax structures (no bills introduced); H.R. 6, 21st Century Cures Act; 
Discussions to clarify or reform the 340B program; 
Biologics Price Competition and Innovation Act;
H.R. 2031, TEST Act;
H.R. 1101 & S. 1287, Viral Hepatitis Testing Act; 
Public Law 111-148, The Patient Protection and Affordable Care Act; 
Implementation of The Prescription Drug User Fee Act (PDUFA); H.R.2029, Military Construction and Veterans Affairs and Related Agencies Appropriations Act;
H.R. 3547, Consolidated Appropriations Act of 2014;
Other Labor, Health and Human Services Appropriations (No Bills Introduced); 
H.R. 1078, Food & Drug Administration Safety Over Sequestration Act; 
S. 1413, FDA User Fee Protection Act; Policies to enhance patient access to medicines in Medicaid;
Policies to enhance patient access to medicines in Medicare; 
H.R. 2925, Strengthening Medicare Anti-Fraud Measures Act; 
H.R. 3061 & S. 31, Medicare Prescription Drug Price Negotiation Act of 2015; 
H.R. 3261 & S. 1884, Medicare Prescription Drug Savings and Choice Act of 2015;
H.R. 3261 & S. 1884, Medicare Prescription Drug Savings and Choice Act of 2015;
S. 2023, Prescription Drug Affordability Act of 2015
Medicare payment proposals; H.R. 3116, MODDERN Cures Act of 2013; 
S. 3004, Dormant Therapies Act of 2014;
H.R. 406 & S. 1767, Combination Drug Development Incentive Act of 2015; 
H.R. 1537 & S. 1878, Advancing Hope Act of 2015;
S. 632, STRONG Patents Act of 2015; 
H.R. 9, Innovation Act; 
H.R. 971 & S. 1421, Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2015; 
Proposals/Initiatives related to international intellectual property protection; Trans-Pacific Partnership Agreement; 
Trade Promotion Authority;
H.R. 1890 & S. 995, Bipartisan Congressional Trade Priorities and Accountability Act of 2015;
TAX - Taxation/Internal Revenue Code HCR - Health Issues BUD - Budget/Appropriations MMM - Medicare/Medicaid CPT - Copyright/Patent/Trademark TRD - Trade (domestic/foreign)
34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 113 - Patent & Trademark Office (PTO) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 113 - Patent & Trademark Office (PTO) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 113 - Patent & Trademark Office (PTO) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 113 - Patent & Trademark Office (PTO) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 113 - Patent & Trademark Office (PTO) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 113 - Patent & Trademark Office (PTO) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR)
ABBVIE, INC.
1399 New York Avenue NW, Suite 600, Washington, DC, 20005, US
MICHAEL D BOYD ANDREW KAPLAN HEATHER STRAWN JOHN P. FORD MICHAEL D BOYD CATHERINE DRATZ FERGUSON JOHN P. FORD ANDREW KAPLAN HEATHER STRAWN STEPHEN SCANGO CATHERINE DRATZ FERGUSON JOHN P. FORD ANDREW KAPLAN HEATHER STRAWN JOHN P. FORD ANDREW KAPLAN HEATHER STRAWN STEPHEN SCANGO CATHERINE DRATZ FERGUSON JOHN P. FORD ANDREW KAPLAN HEATHER STRAWN CATHERINE DRATZ FERGUSON MICHAEL D BOYD STEPHEN SCANGO CATHERINE DRATZ FERGUSON ANDREW KAPLAN MICHAEL D BOYD JOHN P. FORD STEPHEN SCANGO